The use of fetal calf serum (FCS) for the culture of cells to be used in clinical trials raises potential hazards that cannot be neglected, but this is a regulatory issue.

• 应用胎牛血清培养细胞用于临床实验会增加潜在的危险，这是一个可以调控的问题。